Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

TSMC is likely to build the Tensor G5 chipset for the Pixel 10, and it could use a 3-nanometer process. • Renders claiming to show off the Pixel 10 models have surfaced. • A new Pixel Sense AI ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy ... eliminate insulin use by the data cutoff point. Of 10 participants who completed a follow-up visit on ...

Vertex Pharmaceuticals Incorporated (Nasdaq ... space with a nationally recognized healthcare services... at 16:10 The Trade Desk Appoints Will Platt-Higgins as Executive Vice President of ...

The news release and any accompanying... at 16:10 Vertex to Announce First Quarter 2025 Financial Results on May 5th Vertex Pharmaceuticals Incorporated will report its first quarter 2025 ...

Department of Mathematics, Michigan State University, East Lansing, Michigan 48824, United States Department of Mathematics, Michigan State University, East Lansing, Michigan 48824, United States ...